Clinical Trial

Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples

Study acronym: DBS-VB
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see whether dried blood spot (DBS) samples can measure inflammatory biomarkers as accurately as venous blood samples. Investigators will be measuring inflammatory biomarkers changes obtained in DBS compared with paired venous blood samples following a controlled physiological stressor (i.e. after a vaccine or other planned event that can cause a temporary rise in inflammation). These findings will help understand whether DBS can be a reliable alternative to traditional blood draws in future research and healthcare.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-20.
Trial Details
NCT Number NCT07435285
Lead Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborators: Sensifai Health
Conditions Inflammation, Inflammation Biomarkers, Blood Sampling, Dried Blood Spot
Enrollment 50 participants
Start Date 2026-01-15
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-27